7 documents found, page 1 of 1
Late peripheral facial paralysis after COVID-19: a rapid systematic review and ...
Cavalcante,Thalitta Mendes; Gubert,Vanessa Terezinha; Lima,Carolina de Deus; Luciano,Larissa Anjos; Croda,Mariana Garcia; Venturini,JamesAbstract Peripheral facial paralysis (PFP) has been shown to be a neurological manifestation of COVID-19. The current study presents two cases of PFP after COVID-19, along with a rapid review of known cases in the literature. Both case reports were conducted following CARE guidelines. We also performed a systematic review of PFP cases temporally related to COVID-19 using PubMed, Embase, and Cochrane Library dat...
Treatment compliance of patients with paracoccidioidomycosis in Central-West Br...
Andrade,Ursulla Vilella; Oliveira,Sandra Maria do Valle Leone de; Chang,Marilene Rodrigues; Pereira,Edy Firmina; Marques,Ana Paula da CostaABSTRACT Objective: To evaluate the treatment compliance of patients with paracoccidioidomycosis. Methods: We studied 188 patients with paracoccidioidomycosis admitted to a tertiary referral hospital in the Central-West Region of Brazil from 2000 to 2010, to assess their compliance to treatment. In order to be considered compliant, patients needed to present two established criteria: (1) receive medicines from ...
Work of family health strategy nurses in oncology care
Souza,Geize Rocha Macedo de; Cazola,Luiza Helena de Oliveira; Oliveira,Sandra Maria do Valle Leone deAbstract Objective: To identify the qualification of and to know the work of Family Health Strategy nurses in oncology care. Methods: A cross-sectional, descriptive study, using a quantitative approach, was conducted with 77 nurses working in the Family Health Strategy units of Campo Grande, state of Mato Grosso do Sul. Primary data were collected in structured interviews, using a form with closed-ended questio...
Frequency of indeterminate results from an interferon-gamma release assay among...
Oliveira,Sandra Maria do Valle Leone de; Trajman,Anete; Paniago,Anamaria Mello Miranda; Motta-Castro,Ana Rita Coimbra; Ruffino-Netto,AntonioABSTRACT Objective: To evaluate the frequency of and factors associated with indeterminate interferon-gamma release assay (IGRA) results in people living with HIV/AIDS (PLWHA). Methods: We tested 81 PLWHA in the central-west region of Brazil, using the tuberculin skin test and an IGRA. Information on sociodemographic and clinical variables was gathered through the use of questionnaires and from medical records....
Prevalence of latent tuberculosis and treatment adherence among patients with c...
Chagas,Aucely Corrêa Fernandes; Hans Filho,Günter; Oliveira,Sandra Maria do Valle Leone de; Ivo,Maria Lúcia; Corrêa Filho,Ruy Alberto CaetanoIntroduction The primary strategy for tuberculosis control involves identifying individuals with latent tuberculosis. This study aimed to estimate the prevalence of latent tuberculosis in chronic kidney disease (CKD) patients who were undergoing hemodialysis in Campo Grande, State of Mato Grosso do Sul, Brazil, to characterize the sociodemographic and clinical profiles of patients with latent tuberculosis, to v...
Teste tuberculínico: pesquisa operacional no Mato Grosso do Sul
Oliveira,Sandra Maria do Valle Leone de; Ruffino-Netto,Antônio; Paniago,Anamaria Mello Miranda; Oliveira,Olcinei Alves de; Marques,MarliOBJETIVO: Investigar a operacionalização da utilização do teste tuberculínico (TT) em programas de controle de tuberculose e em serviços de assistência especializada do Programa Nacional de Doenças Sexualmente Transmissíveis/AIDS e Hepatites Virais em municípios prioritários para o controle da tuberculose no estado de Mato Grosso do Sul. MÉTODOS: Estudo epidemiológico descritivo, transversal, do tipo inquérito....
Efeito booster na prova tuberculínica em um hospital universitário de Mato Gros...
Oliveira,Sandra Maria do Valle Leone de; Honer,Michael Robin; Paniago,Anamaria Mello Miranda; Aguiar,Eliana Setti; Cunha,Rivaldo Venâncio daA triagem tuberculínica tem por objetivo realizar o rastreio da infecção tuberculosa. Uma retestagem em uma a três semanas tem sido recomendada quando a prova tuberculínica for < 10 mm na 1ª dose para averiguar a ocorrência do efeito booster. Quando a prova tuberculínica for < 10 mm na 1ª dose e, uma a três semanas depois, na 2ª dose, ocorrer uma enduração > 10 mm com aumento de pelo menos 6 mm em relação à ...